Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study

doi:10.4239/wjd.v15.i2.220

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1450)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

WORD

HTML

894

Figures (1-5)

Tables (1-1)

Sum=1131

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

153

Sum=228

Feb 15, 2024 (publication date) through May 15, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Diabetes. Feb 15, 2024; 15(2): 220-231
Published online Feb 15, 2024. doi: 10.4239/wjd.v15.i2.220

Open in New Tab Full Size Figure Download Figure

Figure 1 Mendelian randomization design for causal analysis of viral hepatitis, chronic hepatitis B, chronic hepatitis C and type 2 diabetes. VH: Viral hepatitis; CHB: Chronic hepatitis B; CHC: Chronic hepatitis C; T2D: Type 2 diabetes; GWAS: Genome-wide association studies; SNP: Single nucleotide polymorphisms; LD: Linkage disequilibrium.

Open in New Tab Full Size Figure Download Figure

Figure 2 Forest plot of Mendelian randomization analysis on the causal relationship between viral hepatitis, chronic hepatitis B, chronic hepatitis C and type 2 diabetes. VH: Viral hepatitis; CHB: Chronic hepatitis B; CHC: Chronic hepatitis C; T2D: Type 2 diabetes; OR: Odd ratio; SNP: Single nucleotide polymorphisms; MR: Mendelian randomization; CI: Confidence interval; IVW: Inverse variance weighting.

Open in New Tab Full Size Figure Download Figure

Figure 3 Scatter plot of Mendelian randomization analysis on the causal relationship between viral hepatitis, chronic hepatitis B, chronic hepatitis C and type 2 diabetes. A: Viral hepatitis on type 2 diabetes; B: Chronic hepatitis B on type 2 diabetes; C: Chronic hepatitis C on type 2 diabetes. VH: Viral hepatitis; CHB: Chronic hepatitis B; CHC: Chronic hepatitis C; T2D: Type 2 diabetes; MR: Mendelian randomization.

Open in New Tab Full Size Figure Download Figure

Figure 4 Funnel plot of heterogeneity analysis on viral hepatitis, chronic hepatitis B, chronic hepatitis C and type 2 diabetes. A: Viral hepatitis on type 2 diabetes; B: Chronic hepatitis B on type 2 diabetes; C: Chronic hepatitis C on type 2 diabetes. MR: Mendelian randomization.

Open in New Tab Full Size Figure Download Figure

Figure 5 The results of leave-one-out sensitivity analysis on viral hepatitis, chronic hepatitis B, chronic hepatitis C and type 2 diabetes. A: Viral hepatitis on type 2 diabetes; B: Chronic hepatitis B on type 2 diabetes; C: Chronic hepatitis C on type 2 diabetes. VH: Viral hepatitis; CHB: Chronic hepatitis B; CHC: Chronic hepatitis C; T2D: Type 2 diabetes.

Citation: Yu YF, Hu G, Tong KK, Yang XY, Wu JY, Yu R. Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study. World J Diabetes 2024; 15(2): 220-231
URL: https://www.wjgnet.com/1948-9358/full/v15/i2/220.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i2.220